Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02564549 · ClinicalTrials.gov registry record · NA
MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Ca
A NA study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02564549 is a NA study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 28 participants.
The verdict
NCT02564549, a NA study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Phase II non-inferiority randomized trial of annual systematic biopsies versus mpMRI and targeted biopsies for men with low risk prostate cancer on active surveillance with any volume Gleason's Score 6, but no prior MRI imaging of the prostate.
Interventions
- PROCEDURE TRUS-guided biopsy
- PROCEDURE mpMRI with targeted biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-10-05 |
| Est. Completion | 2017-10-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02564549
The ClinicalTrials.gov registry entry for NCT02564549 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TRUS-guided biopsy is the first listed.
NCT02564549 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02564549 about?
NCT02564549 is a clinical study titled "MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Ca". Phase II non-inferiority randomized trial of annual systematic biopsies versus mpMRI and targeted biopsies for men with low risk prostate cancer on active surveillance with any volume Gleason's Score 6, but no prior MRI imaging of the prostate.
What is the current status of trial NCT02564549?
This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2015-10-05. Estimated completion is 2017-10-13.
What interventions are being tested in trial NCT02564549?
The interventions under investigation include: TRUS-guided biopsy (PROCEDURE), mpMRI with targeted biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02564549?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.